PUBLICATION
CORRECTION: Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia
- Authors
- He, B.L., Yang, N., Man, C.H., Ng, N.K., Cher, C.Y., Leung, H.C., Kan, L.L., Cheng, B.Y., Lam, S.S., Wang, M.L., Zhang, C.X., Kwok, H., Cheng, G., Sharma, R., Ma, A.C., So, C.W.E., Kwong, Y.L., Leung, A.Y.
- ID
- ZDB-PUB-220906-212
- Date
- 2020
- Source
- EMBO Molecular Medicine 12: e12911 (Other)
- Registered Authors
- Keywords
- none
- MeSH Terms
- none
- PubMed
- 32767634 Full text @ EMBO Mol. Med.
Citation
He, B.L., Yang, N., Man, C.H., Ng, N.K., Cher, C.Y., Leung, H.C., Kan, L.L., Cheng, B.Y., Lam, S.S., Wang, M.L., Zhang, C.X., Kwok, H., Cheng, G., Sharma, R., Ma, A.C., So, C.W.E., Kwong, Y.L., Leung, A.Y. (2020) CORRECTION: Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia. EMBO Molecular Medicine. 12:e12911.
Abstract
Chi Wai Eric So's name had been spelled incorrectly. The spelling is herewith corrected.
Errata / Notes
This article corrects ZDB-PUB-200307-7.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping